ScholarLens Back to search
1996•Journal of Aerosol MedicineRequires access

Glutathione in Bronchial Hyperresponsiveness

S. Bernorio, Miriam Pecis, A. ZUCCHI, G. GUERRA, V. MIGLIORINI, Luis De Negri, A Corsano

Open publisher page 5 citations

Abstract

Alterations of oxidants and antioxidants now appear to be pivotal in the development of bronchial hyperresponsiveness and bronchial asthma. To evaluate the potential protective role of the antioxidant reduced glutathione (GSH) administered by ultrasonic nebulizer on metacholine-induced bronchoconstriction, we designed a double-blind, randomized study enrolling 18 subjects with mild asthma and previous bronchoconstriction after a methacholine challenge; we did not find a statistically significant decrease in bronchoconstriction after premedication with inhaled GSH. Further investigation under different experimental conditions is warranted because our information about the mode of action and pharmacokinetics of GSH is still incomplete and sometimes the data are conflicting.

About this research paper

What this paper is about

Alterations of oxidants and antioxidants now appear to be pivotal in the development of bronchial hyperresponsiveness and bronchial asthma. To evaluate the potential protective role of the antioxidant reduced glutathione (GSH) administered by ultrasonic nebulizer on metacholine-induced bronchoconstriction, we designed a double-blind, randomized study enrolling 18 subjects with mild asthma and previous bronchoconstriction after a methacholine challenge; we did not find a statistically significant decrease in bronchoconstriction after premedication with inhaled GSH. Further investigation under different experimental conditions is warranted because our information about the mode of action and pharmacokinetics of GSH is still incomplete and sometimes the data are conflicting.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Alterations of oxidants and antioxidants now appear to be pivotal in the development of bronchial hyperresponsiveness and bronchial asthma. To evaluate the potential protective role of the antioxidant reduced glutathione (GSH) administered by ultrasonic nebulizer on metacholine-induced bronchoconstriction, we designed a double-blind, randomized study enrolling 18 subjects with mild asthma and previous bronchoconstriction after a methacholine challenge; we did not find a statistically significant decrease in bronchoconstriction after premedication with inhaled GSH. Further investigation under different experimental conditions is warranted because our information about the mode of action and pharmacokinetics of GSH is still incomplete and sometimes the data are conflicting.

Key concepts: Bronchoconstriction, Methacholine, Bronchial hyperresponsiveness, Asthma, Glutathione, Premedication, Medicine, Pharmacology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Glutathione in Bronchial Hyperresponsiveness — Research Paper | ScholarLens